Literature DB >> 19550369

Pathologic features and biologic importance of colorectal serrated polyps.

Efsevia Vakiani1, Rhonda K Yantiss.   

Abstract

Serrated polyps of the large intestine comprise a heterogeneous group of mucosal lesions that includes nondysplastic polyps, such as hyperplastic polyps and sessile serrated polyps, and polyps that show overt cytologic dysplasia, namely serrated adenomas and mixed hyperplastic/adenomatous polyps. These polyps have received increased recognition over the past 2 decades, as emerging evidence suggests that a subset may be precursors to colorectal carcinomas that lack chromosomal instability. Several investigators have proposed the concept of the "serrated neoplastic pathway" according to which nondysplastic serrated lesions develop progressively severe dysplasia culminating in the development of microsatellite unstable carcinomas that show DNA hypermethylation and BRAF mutations. A subset of hyperplastic polyps and sessile serrated polyps show mutations in the BRAF gene and abnormal DNA methylation, which can, ultimately, affect the promoter regions of key DNA-repair and tumor suppressor genes, such as MLH1 and MGMT, leading to their decreased transcription and microsatellite instability. On the basis of this hypothesis, many authors have proposed that sessile serrated polyps should be treated and surveilled similar to conventional adenomas, although prospective data are lacking. This review describes the clinicopathologic and molecular features of serrated polyps and discusses the current data regarding their biologic significance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19550369     DOI: 10.1097/PAP.0b013e31819923b3

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  5 in total

1.  A study of prostaglandin pathway genes and interactions with current nonsteroidal anti-inflammatory drug use in colorectal adenoma.

Authors:  Todd L Edwards; Martha J Shrubsole; Qiuyin Cai; Guoliang Li; Qi Dai; Douglas K Rex; Thomas M Ulbright; Zhenming Fu; Harvey J Murff; Walter Smalley; Reid Ness; Wei Zheng
Journal:  Cancer Prev Res (Phila)       Date:  2012-05-02

Review 2.  The "SWOT" of BRAF inhibition in melanoma: RAF inhibitors, MEK inhibitors or both?

Authors:  Moriah H Nissan; David B Solit
Journal:  Curr Oncol Rep       Date:  2011-12       Impact factor: 5.075

3.  Genome-wide association study identifies possible genetic risk factors for colorectal adenomas.

Authors:  Todd L Edwards; Martha J Shrubsole; Qiuyin Cai; Guoliang Li; Qi Dai; Douglas K Rex; Thomas M Ulbright; Zhenming Fu; Ryan H Delahanty; Harvey J Murff; Walter Smalley; Reid M Ness; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-05-15       Impact factor: 4.254

4.  Finding sessile serrated adenomas: is it possible to identify them during conventional colonoscopy?

Authors:  Lisandro Pereyra; Estanislao J Gómez; Raquel González; Carolina Fischer; Gastón Babot Eraña; Alfredo G Torres; Leandro Correa; José M Mella; Guillermo N Panigadi; Pablo Luna; Silvia C Pedreira; Daniel G Cimmino; Luis A Boerr
Journal:  Dig Dis Sci       Date:  2014-07-30       Impact factor: 3.199

Review 5.  Head to head: should we adopt the term 'sessile serrated lesion'?

Authors:  Iris D Nagtegaal; Dale C Snover
Journal:  Histopathology       Date:  2022-03-03       Impact factor: 7.778

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.